Citadel Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-68,854
Closed -$1.24M 5610
2020
Q2
$1.24M Sell
68,854
-145,799
-68% -$2.62M ﹤0.01% 2668
2020
Q1
$1.53M Sell
214,653
-296,238
-58% -$2.11M ﹤0.01% 2476
2019
Q4
$12.2M Buy
510,891
+208,700
+69% +$4.98M 0.01% 1065
2019
Q3
$8.11M Sell
302,191
-96,689
-24% -$2.59M ﹤0.01% 1326
2019
Q2
$10.8M Buy
398,880
+357,300
+859% +$9.69M 0.01% 1145
2019
Q1
$1.44M Sell
41,580
-29,201
-41% -$1.01M ﹤0.01% 2555
2018
Q4
$1.38M Sell
70,781
-244,573
-78% -$4.78M ﹤0.01% 2518
2018
Q3
$8.4M Buy
315,354
+161,580
+105% +$4.3M ﹤0.01% 1209
2018
Q2
$5.81M Buy
153,774
+100,106
+187% +$3.78M ﹤0.01% 1311
2018
Q1
$1.75M Buy
53,668
+27,418
+104% +$896K ﹤0.01% 2039
2017
Q4
$1.28M Sell
26,250
-1,022,536
-97% -$49.8M ﹤0.01% 2220
2017
Q3
$56.7M Buy
1,048,786
+560,144
+115% +$30.3M 0.04% 296
2017
Q2
$27.4M Buy
488,642
+218,609
+81% +$12.3M 0.02% 496
2017
Q1
$10.6M Sell
270,033
-62,764
-19% -$2.46M 0.01% 862
2016
Q4
$7.47M Buy
332,797
+222,321
+201% +$4.99M 0.01% 869
2016
Q3
$2.51M Buy
110,476
+78,171
+242% +$1.78M ﹤0.01% 1425
2016
Q2
$762K Sell
32,305
-96,555
-75% -$2.28M ﹤0.01% 1992
2016
Q1
$2.63M Sell
128,860
-1,015,870
-89% -$20.7M ﹤0.01% 1294
2015
Q4
$58.9M Sell
1,144,730
-50,986
-4% -$2.62M 0.06% 257
2015
Q3
$51M Sell
1,195,716
-74,472
-6% -$3.17M 0.05% 328
2015
Q2
$57.9M Buy
1,270,188
+303,618
+31% +$13.8M 0.05% 336
2015
Q1
$36.7M Buy
966,570
+290,598
+43% +$11M 0.03% 470
2014
Q4
$19.1M Buy
675,972
+605,600
+861% +$17.2M 0.02% 678
2014
Q3
$1.78M Sell
70,372
-114,635
-62% -$2.9M ﹤0.01% 1652
2014
Q2
$5.4M Buy
185,007
+169,445
+1,089% +$4.94M 0.01% 1060
2014
Q1
$403K Buy
+15,562
New +$403K ﹤0.01% 2469